amifostine anhydrous and Neoplasms, Otorhinolaryngologic studies

amifostine anhydrous and Neoplasms, Otorhinolaryngologic

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

Excerpt	Relevance	Reference
"Chemoradiation induced oral mucositis was delayed and showed significant lower degrees at all 10 Gy increments (p < 0."	1.30	Daily amifostine given concomitantly to chemoradiation in head and neck cancer. A pilot study. ( Bank, P; Beleites, E; Koscielny, S; Trog, D; Wendt, TG, 1999)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (33.33)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Maier, P	1
Wenz, F	1
Herskind, C	1
Blanchard, P	1
Bourhis, J	1
Lacas, B	1
Le Teuff, G	1
Michiels, S	1
Pignon, JP	1
Trog, D	1
Bank, P	1
Wendt, TG	1
Koscielny, S	1
Beleites, E	1

Studies

Maier, P

Wenz, F

Herskind, C

Blanchard, P

Bourhis, J

Lacas, B

Le Teuff, G

Michiels, S

Pignon, JP

Trog, D

Bank, P

Wendt, TG

Koscielny, S

Beleites, E

Reviews

2 reviews available for amifostine anhydrous and Neoplasms, Otorhinolaryngologic

Article	Year
Radioprotection of normal tissue cells. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2014, Volume: 190, Issue:8 Topics: Amifostine; Cell Survival; Clinical Trials as Topic; DNA Damage; Dose Fractionation, Radiation; Fibr	2014
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015, Volume: 19, Issue:3 Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Squamous Cell; Ch	2015

Article

Year

Radioprotection of normal tissue cells.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2014, Volume: 190, Issue:8

Topics: Amifostine; Cell Survival; Clinical Trials as Topic; DNA Damage; Dose Fractionation, Radiation; Fibr

2014

[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015, Volume: 19, Issue:3

Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Squamous Cell; Ch

2015

Other Studies

1 other study available for amifostine anhydrous and Neoplasms, Otorhinolaryngologic

Article	Year
Daily amifostine given concomitantly to chemoradiation in head and neck cancer. A pilot study. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:9 Topics: Adult; Aged; Amifostine; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Dose F	1999

Article

Year

Daily amifostine given concomitantly to chemoradiation in head and neck cancer. A pilot study.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1999, Volume: 175, Issue:9

Topics: Adult; Aged; Amifostine; Carcinoma, Squamous Cell; Cohort Studies; Combined Modality Therapy; Dose F

1999